Introduction: Myocardial involvement in pericardial diseases and the effect of pericardial in-
INTRODUCTION
Pericardial diseases represent one of the most underdiagnosed cardiovascular conditions in clinical practice due to the absence of well-established diagnostic criteria. 1, 2 This condition has been reported in approximately 1% of hospitalized patients and 5% of necropsies performed in general hospitals. The most common causes of acute pericarditis are represented by a viral infection, frequently labeled as idiopathic due to the difficult identification of the involved virus, followed by bacterial or parasitic infections. 3 Systemic inflammatory diseases, neoplasms, and traumas may represent the underlying cause of the acute inflammation of the peri-and myo-cardium. 4 Although pericarditis is considered a benign condition, its acute complications, such as cardiac tamponade or involvement of the myocardial layer, may lead to life-threatening conditions such as acute heart failure or death. 5 However, although a vast number of studies have investigated the clinical aspects of pericardial diseases, surprisingly few of them have analyzed the extension of the inflammatory process from the pericardium into the myocardium. 6 The first-line diagnostic means for the recognition of peri-myocardial diseases are echocardiography and cardiac magnetic resonance (CMR), whereas computed tomography (CT) is considered a second-line option. 7, 8 The recent improvement in different diagnostic techniques, notably echocardiography, and longer survival times have led to an increase in the recognition of pericardial diseases in recent years. 9 The current literature mentions the possible effects of pericardial effusion accumulation on the general function of the heart, however, it does not state its exact influence on the regional wall motion abnormalities of the left ventricle (LV).
Our hypothesis is that the extension of the inflammatory process from the pericardium to the myocardial layer in acute peri-myocarditis may lead to the alteration of ventricular wall motion, involving the regions near to the affected pericardium.
The aim of our study was to evaluate regional ventricular wall motion abnormalities in patients with acute perimyocarditis using three-dimensional echocardiography.
MATERIAL AND METHODS

Study deSign
This is a prospective observational study, conducted at the 
incluSion criteria
The inclusion criteria were the presence of clinical symptoms of acute chest pain that worsens on breathing or when changing the position of the body, associated with at least one of the following:
• pericardial friction rub;
• PR-or ST-segment modifications on the 12-lead electrocardiogram (ECG), suggestive for pericarditis;
• evidence of pericardial effusion/thickening of the pericardium with at least 5 m on transthoracic ECG.
excluSion criteria
The exclusion criteria were:
• patients presenting with atherosclerotic or thrombotic coronary lesions;
• unstable angina;
• post-infarction angina;
• recent myocardial infarction;
• congestive heart failure;
• cancers;
• history of heart surgery;
• NYHA functional class 4;
• severe valve disease;
• severe renal, hepatic, hematologic or pulmonary disease;
• age below 18 years.
Methodology
Clinical data
The history and clinical data of all enrolled subjects were recorded, including age, gender, cardiovascular risk factors (diabetes mellitus, hypertension, dyslipidemia, smoking, family history of cardiovascular diseases), and personal history (stable/unstable angina, myocardial infarction, ischemic heart disease, stroke).
Paraclinical data
Standard 12-lead resting ECG was obtained from all patients, documenting the existence of any abnormality of the repolarization phase.
Echocardiography was performed using an Agilent Sonos 4500 ultrasound imaging system (Philips, Amsterdam, the Netherlands), and the following parameters were recorded:
• pericardial thickening;
• amount and location of pericardial fluid;
• left ventricular volumes;
• left ventricular ejection fraction;
• contraction abnormalities.
Three-dimensional echocardiography was also performed for the assessment of the following:
• total and regional left ventricular ejection fraction;
• detection of regional wall motion abnormalities;
• calculation of the end-diastolic and end-systolic volume;
• evaluation of the regions with wall motion abnormalities (contraction asynchronies);
• measurement of the delay in maximal global systolic contraction amplitude, assessment of the index of contraction amplitude (ICA);
• regional index of contraction amplitude (RICA);
• the volumetric curve for each ventricular region;
• polar mapping of the delay in maximal systolic contraction amplitude.
For patients in Group 2, the contractility index was calculated for each ventricular region corresponding to the region affected by peri-myocarditis compared to the regions without peri-myocarditis.
As the clinical, laboratory, and ECG findings in acute peri-myocarditis may be similar to ischemic coronary disease, invasive coronary angiography was performed in cases when an acute coronary syndrome could not be ruled out by noninvasive examination.
The study has been carried out in accordance with the code of ethics of the World Medical Association's Declaration of Helsinki. All patients gave written informed consent, and the study protocol was approved by the ethics committee of the institution where the study was conducted.
StatiStical analySiS
JMP statistical software was used for statistical analysis. 
RESULTS
BaSeline and clinical characteriSticS
There was no significant difference between the two study groups regarding age, with a mean of 55.28 ± 11.28 Three-dimensional echocardiographic analysis of the global and regional contractility showed no significant difference between the two study groups in terms of end-diastolic volume (EDV), with a mean of 123.14 ± 
DISCUSSION
Peri-myocarditis can occur at any age, with peak prevalence middle-aged subjects. The mean age of our study population with acute peri-myocarditis was 55.28 ± 11.28
years. Some authors suggest that there may be a difference in respect of age in patients presenting with acute pericarditis versus those showing associated myocardial affection. 10 The literature data is conflicting regarding the sex-related risk of developing peri-myocarditis. 11, 12 In an experi- 
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In the present study female gender was predominant in patients with acute peri-myocarditis (67.85%). These results may be explained by the fact that systemic inflammatory diseases are more common in females, and some authors suggest that progesterone may aggravate myocardial inflammation, though estrogen inhibits the immune response.
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